Cartagenia | GenomeWeb


OneSight is the first standalone commercial software for visualizing and exploring chromosomal aneuploidies from cell-free DNA in research contexts.

Agilent is buying Cartagenia to offer a complete suite of products for NGS and array testing that covers data generation through interpretation.

Agilent is buying the Belgium-based clinical software and services company for an undisclosed sum.

Under the terms of the agreement, customers of Cartagenia's Bench Lab NGS software will have access to N-of-One's clinical interpretation services.

Pathology laboratories using Cartagenia's Bench NGS software will be able to access MedGenome's annotated cancer variant database. 

NEW YORK (GenomeWeb) – CollabRx and Cartagenia have teamed up to provide an end-to-end software solution for clinical laboratories that supports genetic testing and reporting, including next-generation sequencing-based tests, in oncology.

NEW YORK (GenomeWeb) – Cartagenia announced today that it and Qiagen's bioinformatics business are part of a consortium that has received €1.4 million ($1.7 million) in funding from a European funding initiative to support the development of software tools for personalized genetic analysis of can

NEW YORK (GenomeWeb) – Cartagenia said this week that the National Institutes of Health's Undiagnosed Disease Program is using a customized version of its Bench Lab platform, a software solution for assessing and reporting on genetic variants, to analyze mutations that are identified in exome seq

NEW YORK (GenomeWeb) –Life science software firm BioDiscovery this week unveiled NXClinical, a new addition to its product portfolio that's tailored specifically for the clinical laboratory market and provides tools for analyzing, processing, and reporting the results of genetic tests.

NEW YORK (GenomeWeb) – Cartagenia said this week that it intends to use €4.3million ($5.9 million) in private financing to grow its business and to hire between 20 and 30 sales and support staff for its offices in Boston and Leuven, Belgium.


In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.